BIBF 1120 ES

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIBF 1120 ES, covering 2017-12-28 to 2017-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer [Phase 2]